Brought to you by 
Smith & Nephew, Q-Med ally in orthopedics
13 Jul 2006
Executive Summary
Smith & Nephew's Orthopaedics Trauma & Clinical Therapies division has licensed worldwide exclusive rights to develop, market, and distribute orthopedic products based on Q-Med AB's NASHA technology that produces non-animal stabilized hyaluronic acid, which eliminates the risk of allergic reactions and the transmission of diseases from animals.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com